BeOne Medicines Ltd. (ONC) insider trading

By person

28 insiders · 1,707 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

HHLR ADVISORS, LTD. entity

10% owner

—

$4.39B (9)

−$4.39B

125,045,741

$43.92B

−15.0%

OYLER JOHN

Chief Executive Officer

—

$814.13M (776) scheduled

−$814.13M

6,243,246

$2.19B

+131.1%

Wang Xiaodong

Director

—

$153.69M (271) scheduled

−$153.69M

4,588,163

$1.61B

−57.5%

Wu Xiaobin

President and COO

—

$104.80M (150) scheduled

−$104.80M

1,308,161

$459.50M

—

AMGEN INC entity

10% owner

$50.00M (1)

—

+$50.00M

255,193,647

$89.64B

+13.5%

Liang Howard

CFO & Chief Strategy Officer

—

$48.84M (58) scheduled

−$48.84M

1,573,715

$552.77M

—

BAKER BROS. ADVISORS LP entity

Director

$896.76M (8)

$943.56M (16)

−$46.80M

16,662,655

$5.85B

—

Huang Jane

CMO, Hematology

—

$39.74M (199) scheduled

−$39.74M

160,055

$56.22M

—

Lee Chan Henry

SVP, General Counsel

—

$16.39M (44) scheduled

−$16.39M

346,554

$121.73M

—

Glazer Donald W.

Director

—

$11.06M (14)

−$11.06M

2,718,464

$954.87M

−35.3%

Wang Lai

President, Global Head of R&D

—

$9.98M (46) scheduled

−$9.98M

1,710,085

$600.67M

—

Peterson Amy C.

CMO, Immuno-oncology

—

$8.76M (38) scheduled

−$8.76M

269,566

$94.69M

+2.7%

Chen Timothy Yung-Cheng

Director

—

$6.37M (30) scheduled

−$6.37M

7,800

$2.74M

—

Sanders Corazon (Corsee) D.

Director

—

$1.96M (6) scheduled

−$1.96M

57,226

$20.10M

—

Li Ji

EVP and Gl. Head of Bus. Dev.

—

$1.47M (6) scheduled

−$1.47M

$0.00

—

Malley Thomas

Director

$960.00K (1)

—

+$960.00K

76,696

$26.94M

—

Wang Julia Aijun

Chief Financial Officer

—

$953.45K (14)

−$953.45K

456,326

$160.29M

+786.4%

Rosenberg Aaron

Chief Financial Officer

—

$870.11K (3)

−$870.11K

397,891

$139.76M

—

Ball Titus B.

Principal Accounting Officer

—

$227.85K (8)

−$227.85K

97,929

$34.40M

+624.4%

Dugan Margaret

Director

—

$65.64K (1)

−$65.64K

73,164

$25.70M

—

Riva Alessandro

Director

—

$65.62K (1)

−$65.62K

73,164

$25.70M

—

Yi Qingqing

Director

—

$65.60K (1)

−$65.60K

27,326

$9.60M

+11,938%

HOOPER ANTHONY C

Director

—

83,720

$29.41M

—

BRANDICOURT OLIVIER

Director

—

46,306

$16.27M

—

Sharp Shalini

Director

—

38,116

$13.39M

—

Sawyers Charles Lazelle

Director

—

18,984

$6.67M

+474,500%

Mooney Elizabeth Fisher

Director

—

18,980

$6.67M

—

su Jingshyh S

Director

—

7,800

$2.74M

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

BeOne Medicines Ltd.

By person

Individual transactions

What was left out